Stay updated on Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.

Latest updates to the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedAccess to the study record at NCT02866383 is blocked by a 403 Forbidden page, so the study details cannot be viewed. The page still renders site chrome (header, navigation, and footer) but no study information.SummaryDifference19%

- Check50 days agoChange DetectedRevision history shows a new entry for Revision: v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check71 days agoChange DetectedUnderlying site software was upgraded from version 3.6.4 to 3.6.5. This appears to be a routine behind-the-scenes update and does not modify the study content or visible features.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page footer revision updated from v3.6.3 to v3.6.4, indicating a new build of the ClinicalTrials.gov page.SummaryDifference0.1%

Stay in the know with updates to Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.